pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,330 catalysts · 6,086 phase readout · 2,238 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,086
  • 8k filing2,238
  • earnings395
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07310420: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

Sponsor: TerSera Therapeutics LLC. Phase: PHASE1. Conditions: Advanced Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07617220: FIRST-Sask Study Protocol: A Remote Exercise Oncology Intervention

Sponsor: University of Saskatchewan. Phase: NA. Conditions: Exercise Oncology

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07399782: Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea

Sponsor: Hospital Felicio Rocho. Phase: PHASE2. Conditions: Sleep Apnea Syndrome, Obstructive, Sleep Apnea Syndrome (OSAS), Sleep Apnea/Hypopnea Syndrome, Sleep Apnea - Obstructive

full page →ctgov ↗
›COMPLETEDphase readoutNCT07202182: Creative Drama-Based Stress Management Program on Stress, Coping, and Emotional Intelligence

Sponsor: Gazi University. Phase: NA. Conditions: Emotional Intelligence, Creative Drama, Coping, Nursing, Undergraduate

full page →ctgov ↗
›RECRUITINGphase readoutNCT06239259: Validity and Reliability of Thai Version Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome

Sponsor: Siriraj Hospital. Phase: . Conditions: Carpal Tunnel Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07575659: Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental Therapy

Sponsor: Tuba Derya Doğan. Phase: NA. Conditions: Cerebral Palsy, Cerebral Palsy Early Intervention

full page →ctgov ↗
›RECRUITINGphase readoutNCT06048159: Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Stroke, Aphasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07743359: Enhancing Delivery of Parenting Support Within a Peer Recovery Support Service Model

Sponsor: Baystate Medical Center. Phase: NA. Conditions: Substance Use Disorders (SUDs)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07275580: Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases

Sponsor: University of Sao Paulo General Hospital. Phase: PHASE4. Conditions: Autoimmune Rheumatic Diseases, Tooth Extraction, Infection Prevention, Antibiotic Prophylaxis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06629779: A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Sponsor: Pfizer. Phase: PHASE3. Conditions: Metastatic Castration-Resistant Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06095596: Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: NA. Conditions: Ulcerative Colitis (UC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07581496: T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer

Sponsor: University Hospital, Basel, Switzerland. Phase: . Conditions: Bladder Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06857279: A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Sponsor: Shanghai Henlius Biotech. Phase: PHASE2. Conditions: Carcinoma of Head and/or Neck

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06433596: Autologous PRP and Focal Shock Waves for Erectile Dysfunction

Sponsor: Elexial Research Limited. Phase: NA. Conditions: Erectile Dysfunction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07438262: The AminoECMO Pilot Trial

Sponsor: Australian and New Zealand Intensive Care Research Centre. Phase: PHASE2. Conditions: Acute Kidney Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03997162: Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

Sponsor: City of Hope Medical Center. Phase: . Conditions: Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Pathologic Stage 0 Gastric Cancer AJCC v8, Pathologic Stage I Gastric Cancer AJCC v8, Pathologic Stage IA Gastric Cancer AJCC v8, Pathologic Stage IB Gastric Cancer AJCC v8, Pathologic Stage II Gastric Cancer AJCC v8, Pathologic Stage IIA Gastric Cancer AJCC v8, Pathologic Stage IIB Gastric Cancer AJCC v8, Pathologic Stage III Gastric Cancer AJCC v8, Pathologic Stage IIIA Gastric Cancer AJCC v8, Pathologic Stage IIIB Gastric Cancer AJCC v8, Pathologic Stage IIIC Gastric Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT05393362: Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.

Sponsor: University of Malaga. Phase: NA. Conditions: Heart Failure With Preserved Ejection Fraction, Sarcopenia, Frail Elderly Syndrome, Comorbidities and Coexisting Conditions

full page →ctgov ↗
›COMPLETEDphase readoutNCT05598788: Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies

Sponsor: Rennes University Hospital. Phase: . Conditions: Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib

full page →ctgov ↗
›RECRUITINGphase readoutNCT07747103: An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.

Sponsor: Neuvosyn Laboratories, LLC. Phase: PHASE3. Conditions: Hypothyroidism

full page →ctgov ↗
›RECRUITINGphase readoutNCT06218303: Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Sponsor: Finn, Olivera, PhD. Phase: PHASE1. Conditions: Ductal Carcinoma in Situ

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07696403: Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose

Sponsor: University of Georgia. Phase: NA. Conditions: Nutrition, Healthy, Dyslipidemia, Overweight and Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT03985527: Janus Feasibility Study

Sponsor: Respicardia, Inc.. Phase: NA. Conditions: Sleep Apnea Syndromes

full page →ctgov ↗
›COMPLETEDphase readoutNCT06111027: Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Spasmodic Dysphonia, Laryngeal Dystonia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05074927: Pulmonary Function in Patients Recovering From COVID19 Infection : a Pilot Study

Sponsor: University Hospital, Limoges. Phase: NA. Conditions: COVID-19

full page →ctgov ↗
›COMPLETEDphase readoutNCT02553447: Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Sponsor: University of Nebraska. Phase: NA. Conditions: Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Untreated Chronic Lymphocytic Leukemia, Vitamin D Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT05612347: Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Colorectal Polyp, Colorectal Neoplasms, Colorectal Adenoma, Colorectal Cancer, Digestive System Disease

full page →ctgov ↗
›TERMINATEDphase readoutNCT05754749: Comparison of CE-DBT and MRI in Patients With Known Breast Lesions

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03716349: Esthetics of Dental Composite and Adhesive System

Sponsor: Erica Teixeira. Phase: NA. Conditions: Cavities of Teeth

full page →ctgov ↗
›RECRUITINGphase readoutNCT06144749: A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Sponsor: Hillhurst Biopharmaceuticals, Inc.. Phase: PHASE1. Conditions: Anemia, Sickle Cell

full page →ctgov ↗
›COMPLETEDphase readoutNCT05693038: Brachial Plexus Injury After Prone Positioning

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Brachial Plexus Injury, Nerve Compression

full page →ctgov ↗
›COMPLETEDphase readoutNCT06782438: Evaluation of an Artificial Intelligence Algorithm Reducing Noise on Fast Whole-body Bone Tomoscintigraphy Acquisitions Recorded by a 360 Degree Cadmium-Zinc-Tellurid Camera

Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Bone Scan

full page →ctgov ↗
›RECRUITINGphase readoutNCT05209438: Cereset Research for Caregivers

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Caregivers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07221838: A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE4. Conditions: Generalized Myasthenia Gravis, gMG

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06062238: Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults

Sponsor: Gates Medical Research Institute. Phase: PHASE3. Conditions: Tuberculosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07747038: Caudal Block v/s Local Wound Infiltration for Pain Control in Pediatric Patients After Operation for Inguinal Hernia

Sponsor: Fatima Memorial Hospital. Phase: NA. Conditions: Postoperative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07658638: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants

Sponsor: Tes Pharma S.r.l.. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07292038: Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors

Sponsor: NucMito Pharmaceuticals Co. Ltd.. Phase: PHASE1. Conditions: Cancers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07336238: Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Sponsor: University of Washington. Phase: PHASE2. Conditions: Anxiety, Depression, Hematopoietic and Lymphatic System Neoplasm, Metastatic Malignant Solid Neoplasm

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07223138: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

Sponsor: MoonLake Immunotherapeutics AG. Phase: PHASE3. Conditions: Arthritis, Psoriatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT02926547: New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement

Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05358249: Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Colorectal Cancer, Colorectal Carcinoma, Colorectal Neoplasms, Colorectal Tumors, Neoplasms, Colorectal

full page →ctgov ↗
›RECRUITINGphase readoutNCT07434349: Exercise Timing and Postprandial Glucose Responses

Sponsor: Technical University of Munich. Phase: NA. Conditions: Exercise Timing, Postprandial Glucose

full page →ctgov ↗
›RECRUITINGphase readoutNCT07531849: Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas

Sponsor: University of Paris 13. Phase: NA. Conditions: Self-Efficacy, Food Choices, Understanding of Front-of-pack Labeling

full page →ctgov ↗
›COMPLETEDphase readoutNCT07335549: Istmin Levels in Laparoscopik Sleeve Gastrectomy

Sponsor: Saglik Bilimleri Universitesi. Phase: . Conditions: Obesity & Overweight, Sleeve Gastrectomy, Adipokines

full page →ctgov ↗
›RECRUITINGphase readoutNCT06203938: Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

Sponsor: Francisco Gonzalez-Lima, PhD. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07371338: Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

Sponsor: Innopeutics Corporation. Phase: PHASE1. Conditions: Parkinson Disease, Parkinson's Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07358338: Application of Device-based Training to Improve Postural Control in Older Adults With CCI

Sponsor: Litvina Lyubov Dmitrievna. Phase: NA. Conditions: Cerebrovascular Disorders, Gait Disorders, Neurologic, Accidental Fall, Aged, Postural Balance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06692738: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06495658: Impact of Prebiotics in Ulcerative Colitis

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Crohn Disease, Ulcerative Colitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05085548: ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Sponsor: ProDa BioTech, LLC. Phase: PHASE1. Conditions: Advanced Pancreatic Cancer, Solid Tumor Malignancies

full page →ctgov ↗
← prev
page 157 of 167
next →